← Back to Search

SARS-CoV-2 Testing for Dialysis Patients

N/A

Waitlist Available

Led By Shuchi Anand, MD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Patient treatment at US Renal Care in-center hemodialysis facility

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trialaims to protect dialysis patients from SARS-CoV-2 exposure with universal testing and varying frequencies depending on local case rates. Outcomes include test acceptability, lower death and hospitalization rates, and better experience-of-care metrics.

Who is the study for?

This trial is for adults over 18 who are receiving in-center hemodialysis at US Renal Care facilities and agree to share their health data. Facilities must be willing to participate and located in counties with multiple centers. Patients with dementia or cognitive impairments unable to understand opting out, or those unwilling to share routine clinical samples, cannot join.Check my eligibility

What is being tested?

The study tests two SARS-CoV-2 screening strategies in dialysis facilities: a static approach offering tests every two weeks, versus a dynamic approach adjusting test frequency based on local COVID-19 cases. The goal is to see which method leads to better acceptance of testing and lower rates of COVID-related death and hospitalization.See study design

What are the potential side effects?

Since the intervention involves only offering SARS-CoV-2 screening tests without additional medical procedures, there are no direct side effects from the intervention itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I receive my hemodialysis at a US Renal Care center.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Test acceptance rate

Secondary outcome measures

Change in facility scores on In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems (ICH CAHPS) Survey

Deaths

Hospitalizations

Trial Design

2Treatment groups

Active Control

Group I: Dynamic frequencyActive Control1 Intervention

Test based screening for SARS-CoV-2 ranging from once a week to once every four weeks anchored to county COVID-19 case rates

Group II: Static frequencyActive Control1 Intervention

Test based screening for SARS-CoV-2 every two weeks

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,388 Previous Clinical Trials

17,332,038 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

382 Previous Clinical Trials

1,213,772 Total Patients Enrolled

National Institute of Allergy and Infectious Diseases (NIAID)NIH

3,269 Previous Clinical Trials

5,479,079 Total Patients Enrolled

Media Library

Offering SARS-CoV-2 test Clinical Trial Eligibility Overview. Trial Name: NCT05225298 — N/A

Kidney Disease Research Study Groups: Dynamic frequency, Static frequency

Kidney Disease Clinical Trial 2023: Offering SARS-CoV-2 test Highlights & Side Effects. Trial Name: NCT05225298 — N/A

Offering SARS-CoV-2 test 2023 Treatment Timeline for Medical Study. Trial Name: NCT05225298 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to partake in this research initiative?

"This research effort, which was initially posted on February 6th 2023 and last updated two days later, is not currently seeking new patients. Nonetheless, there are numerous other clinical trials actively recruiting participants right now numbering 1119 in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SARS-COV-2 Screening in Dialysis Facilities

Shuchi Anand 2023. "SARS-COV-2 Screening in Dialysis Facilities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05225298.